title: Summary statement: biologics for spine fusion.
authors.forename: Jonathan N
authors.initials: JN
authors.lastname: Grauer
authors.forename: Louis G
authors.initials: LG
authors.lastname: Jenis
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Wang
authors.forename: Francis H
authors.initials: FH
authors.lastname: Shen
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Fischgrund
authors.forename: Frank M
authors.initials: FM
authors.lastname: Phillips
mesh_terms: D000818:Animals; D001688:Biological Products / Q000494:pharmacology*; D006801:Humans; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013122:Spinal Diseases / Q000473:pathology / Q000628:therapy*; D013123:Spinal Fusion / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D001688:Biological Products